2024-01-08 NHLBI BioData Catalyst Ecosystem Release Notes
Previous2024-04-01 NHLBI BioData Catalyst Ecosystem Release NotesNext2023-10-04 NHLBI BioData Catalyst Ecosystem Release Notes
Last updated
Was this helpful?
Last updated
Was this helpful?
The 2024-01-08 release marks the 16th release for the NHLBI BioData Catalyst® (BDC) ecosystem. This release includes several new features (e.g., enabling Azure and searching data without logging in) along with documentation and tutorials (e.g., data dictionary field documentation) to help new users get started on the system. Please find more detail on the new features and user support materials in the sections below.
The 2024-01-08 data releases include the addition of research on multisystem inflammatory syndrome in children linked to COVID-19, bone marrow transplant and pulmonary hypertension in sickle cell disease, atherosclerosis, and psoriasis. Please refer to the Data Releases section below for more information as well as the on the BDC website.
Azure available on BDC Powered by Seven Bridges (BDC-SB): Velsera expanded their existing multi-cloud offerings by enabling Microsoft Azure (southcentralus) on BDC-SB. Users can select that computing and storage environment when creating a project. This allows users to avoid any egress charges when computing on data stored in Azure. This is of particular interest to users who want to connect their own Azure cloud buckets to BDC-SB.
SAS upgrade in BDC-SB: SAS on BDC-SB has been upgraded from SAS Viya 3.5 to SAS Studio 9.4. SAS 9.4 has improved functionality over SAS 3.5 including more complete data management solutions and additional programming languages.
Open PIC-SURE without login: Open PIC-SURE is now publicly available on BDC Powered by PIC-SURE (BDC-PIC-SURE), meaning no eRA Commons credentials are required to access the site. Researchers can access this site to search terms of interest, apply filters at the variable-value level, retrieve obfuscated, aggregate counts, and view single variable distributions of their selected cohort. This new functionality allows researchers to discover and interact with data available on BDC without needing to log in, decreasing the barrier to data exploration. Check out Open PIC-SURE .
Data Hierarchies in BDC-PIC-SURE: Researchers are now able to view the data hierarchy associated with variables in BDC-PIC-SURE by clicking the “Data Tree” icon in the “Actions” column of the search results. This enables researchers to understand better how variables are related and obtain additional context for these variables. Note that this feature is currently in beta and will only be available for some studies. Feedback and input on this feature is welcome!
BDC-PIC-SURE Data Dictionary fields documentation: Documentation outlining the data dictionary fields returned from the PIC-SURE API was created. This provides a detailed account of what each field represents, including relationships between fields. This documentation can be found in the BDC-PIC-SURE GitBook .
The table below highlights which studies were included in the 2024-01-08 data release. The release features research on long-term outcomes of multisystem inflammatory syndrome in children linked to COVID-19 (COVID19-MUSIC_GRU), bone marrow transplant for severe sickle cell disease (BioLINCC-BMT_CTN_HMB), and ApoA-1, atherosclerosis, and psoriasis (DIR-ApoA-1_Atherosclerosis_in_Psoriasis_GRU). Additionally, updated metadata is provided for the ongoing study on sildenafil therapy in treating pulmonary hypertension in sickle cell disease (walk-PHaSST). This data includes clinical files and is now available for access. The data is now available for access across the entire ecosystem.
Long-TerM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC)
phs002770.v1.p1.c1
COVID19-MUSIC_GRU
Yes
Yes
Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children with Severe Sickle Cell Disease (BMT CTN-0601-BioLINCC)
phs003470.v1.p1.c1
BioLINCC-BMT_CTN_HMB
Yes
Yes
ApoA-1 and Atherosclerosis in Psoriasis (DIR)
phs003231.v1.p1.c1
DIR-ApoA-1_Atherosclerosis_in_Psoriasis_GRU
Yes
Yes
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy (walk-PHaSST)
phs002383.v1.p1.c1
BioLINCC-Walk_PHaSST_DS-SCD-IRB-PUB-COL-NPU-MDS-RD
No
No
Genetic Epidemiology of COPD Study (COPDGene)
phs002910.v1.p1.c1
COVID19-C4R_COPDGene_HMB
Yes
Yes
Genetic Epidemiology of COPD Study (COPDGene)
phs002910.v1.p1.c2
COVID19-C4R_COPDGene_DS-CS
Yes
Yes
The Mediators of Atherosclerosis in South Asians Living in America (MASALA)
phs002980.v1.p1.c1
COVID19-C4R_MASALA_HMB-IRB-COL
Yes
Yes
Prevent Pulmonary Fibrosis (PrePF)
phs002975.v1.p1.c1
COVID19-C4R_PrePF_HMB
Yes
Yes
A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults (RECOVER)
phs003463.v1.p1.c1
RECOVER-Adult
Yes
Yes
Hispanic Community Health Study (HCHS)
phs003457.v1.p1.c1
NSRR-HCHS
Yes
Yes
Hispanic Community Health Study (HCHS)
phs003457.v1.p1.c2
NSRR-HCHS
Yes
Yes
NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica (CRA)
phs000988.v5.p1.c1
topmed-CRA_DS-ASTHMA-IRB-MDS-RD
No
Yes
NHLBI TOPMed - NHGRI CCDG: Genes-Environments and Admixture in Latino Asthmatics (GALA II)
phs000920.v5.p2.c2
topmed-GALAII_DS-LD-IRB-COL
No
Yes
NHLBI TOPMed: HyperGEN - Genetics of Left Ventricular (LV) Hypertrophy
phs001293.v3.p1.c1
topmed-HyperGEN_GRU-IRB
No
Yes
NHLBI TOPMed: HyperGEN - Genetics of Left Ventricular (LV) Hypertrophy
phs001293.v3.p1.c2
HyperGEN_DS-CVD-IRB-RD
No
Yes
NHLBI TOPMed: Whole Genome Sequencing of Venous Thromboembolism (WGS of VTE)
phs001402.v3.p1.c1
Mayo_VTE_GRU
No
Yes
NHLBI TOPMed - NHGRI CCDG: Massachusetts General Hospital (MGH) Atrial Fibrillation Study
phs001062.v5.p2.c2
MGH_AF_DS-AF-IRB-RD
No
Yes
NHLBI TOPMed - NHGRI CCDG: Massachusetts General Hospital (MGH) Atrial Fibrillation Study
phs001062.v5.p2.c1
MGH_AF_HMB-IRB
No
Yes
NHLBI TOPMed: African American Sarcoidosis Genetics Resource
phs001207.v3.p1.c1
Sarcoidosis_DS-SAR-IRB
No
Yes
NHLBI TOPMed: Women's Health Initiative (WHI)
phs001237.v3.p1.c1
WHI_HMB-IRB
No
Yes
NHLBI TOPMed: Women's Health Initiative (WHI)
phs001237.v3.p1.c2
WHI_HMB-IRB-NPU
No
Yes
NHLBI TOPMed - NHGRI CCDG: Atherosclerosis Risk in Communities (ARIC)
phs001211.v4.p2.c2
ARIC_DS-CVD-IRB
No
Yes
NHLBI TOPMed - NHGRI CCDG: Atherosclerosis Risk in Communities (ARIC)
phs001211.v4.p2.c1
ARIC_HMB-IRB
No
Yes
NHLBI TOPMed: Genetics of Cardiometabolic Health in the Amish
phs000956.v5.p1.c2
Amish_HMB-IRB-MDS
No
Yes
NHLBI TOPMed: Australian Familial Atrial Fibrillation Study
phs001435.v2.p1.c1
AustralianFamilialAF_HMB-NPU-MDS
No
Yes
NHLBI TOPMed - NHGRI CCDG: Early-onset Atrial Fibrillation in the CATHeterization GENetics (CATHGEN) Cohort
phs001600.v3.p2.c1
CATHGEN_DS-CVD-IRB
No
Yes
NHLBI TOPMed: Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)
phs001472.v2.p1.c1
ECLIPSE_DS-COPD-MDS-RD
No
Yes
NHLBI TOPMed: Genetic Epidemiology Network of Arteriopathy (GENOA)
phs001345.v3.p1.c1
GENOA_DS-ASC-RF-NPU
No
Yes
NHLBI TOPMed: Genetic Epidemiology Network of Salt Sensitivity (GenSalt)
phs001217.v3.p1.c1
GenSalt_DS-HCR-IRB
No
Yes
NHLBI TOPMed: GOLDN Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
phs001359.v3.p1.c1
GOLDN_DS-CVD-IRB
No
Yes
NHLBI TOPMed: Defining the time-dependent genetic and transcriptomic responses to cardiac injury among patients with arrhythmias
phs001434.v2.p1.c1
miRhythm_GRU
No
Yes
NHLBI TOPMed: Partners HealthCare Biobank
phs001024.v5.p1.c1
PARTNERS_HMB
No
Yes
NHLBI TOPMed: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease (PharmHU)
phs001466.v2.p1.c3
pharmHU_DS-SCD
No
Yes
NHLBI TOPMed: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease (PharmHU)
phs001466.v2.p1.c2
pharmHU_DS-SCD-RD
No
Yes
NHLBI TOPMed: Pharmacogenomics of Hydroxyurea in Sickle Cell Disease (PharmHU)
phs001466.v2.p1.c1
pharmHU_HMB
No
Yes
NHLBI TOPMed: REDS-III Brazil Sickle Cell Disease Cohort (REDS-BSCDC)
phs001468.v3.p1.c1
REDS-III_Brazil_SCD_GRU-IRB-PUB-NPU
No
Yes
NHLBI TOPMed: San Antonio Family Heart Study (SAFHS)
phs001215.v4.p2.c1
SAFHS_DS-DHD-IRB-PUB-MDS-RD
No
Yes
NHLBI TOPMed: Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)
phs001467.v2.p1.c1
SAPPHIRE_asthma_DS-ASTHMA-IRB-COL
No
Yes
NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women
phs001040.v5.p1.c1
WGHS_HMB
No
Yes
BDC-Gen3 release notes